Key statistics
Valuation, profitability, and growth metrics
- Market cap
- 232.79M USD
- Enterprise value
- 115.65M USD
- Trailing P/E
- —
- Forward P/E
- 3.00
- Price / sales
- 4.34
- Price / book
- 1.41
- EV / EBITDA
- -10.96
- Beta
- 0.89
- Dividend yield
- —
- Profit margin
- -5.19%
- Return on equity
- -1.49%
- Debt / equity
- 0.27
- Earnings growth
- -65.30%
- Revenue growth
- -49.50%
- Free cash flow
- -23.99M USD
- Operating cash flow
- -20.17M USD
- Shares outstanding
- 71.85M
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
Updated Sep 2, 2026, 4:15 AM